Pharmaceutical

OZMOSI and Planview partner to enhance pharmaceutical d...

The initiative aims to link external scientific data with internal R&D planning ...

IPC signs MoUs with PMBI and NIPER Hajipur to strengthe...

Agreements focus on medicine quality testing, pharmacovigilance, and pharmaceut...

Raay Neo Pharma launches operations with portfolio of 9...

Company outlines expansion across multiple states and pipeline of formulations ...

Sanofi receives FDA approval for Tzield in paediatric d...

The approval expands the previous indication from those aged eight and above and...

PAGE partners with 8chili to launch AI and VR training ...

Platform to support workforce development for quality, production and regulator...

Kashiv BioSciences to be acquired by Amneal Pharmaceuti...

Transaction to create integrated global biosimilars platform combining developm...

MSD teams up with Google Cloud on agentic AI transforma...

The collaboration aims to implement an agentic platform across MSD’s research an...

Safeguarding the pharma excipients supply chain

Adding excipient details to QR codes of the top 300 drugs may not be a tough ta...

BioAegis and Prenosis partner for inflammatory disease ...

The collaboration will evaluate biomarkers and patient subgroups with improved r...

Health Canada approves Biocon’s two denosumab biosimilars

The approval covers Bosaya in a 60mg/ml prefilled syringe and Vevzuo in a 120mg/...

Off label drug use and physician liability

Dr Amit Kumar, Assistant Professor of Law, Maharashtra National Law University ...

Supriya Lifescience receives USFDA EIR with VAI classif...

Inspection cycle closed following February 2026 USFDA audit The post Supriya Li...

Lupin launches Dapagliflozin and Metformin extended-rel...

USFDA approves ANDA for bioequivalent version of Xigduo XR The post Lupin laun...

Pfizer and Astellas secure FDA priority review for Padc...

The application aims to allow the use of this combination therapy for all patien...

Asahi Kasei acquires German company Aicuris

The move comes after Asahi Kasei signed a definitive agreement to acquire all is...

OneSource and Orbicular secure USFDA tentative approval...

Partnership progresses ANDA filing for generic version of Ozempic with manufact...